These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 2605612

  • 1. [Prevention of recurrent urinary infections using Solco Urovac, a polymicrobial vaccine].
    Prát V, Matousovic K, Horcicková M, Hatala M, Milotová Z.
    Cas Lek Cesk; 1989 Aug 25; 128(35):1106-9. PubMed ID: 2605612
    [Abstract] [Full Text] [Related]

  • 2. Role of the bacterial vaccine Solco-Urovac® in treatment and prevention of recurrent urinary tract infections of bacterial origin.
    Kochiashvili D, Khuskivadze A, Kochiashvili G, Koberidze G, Kvakhajelidze V.
    Georgian Med News; 2014 Jun 25; (231):11-6. PubMed ID: 25020163
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Immunotherapy and long-term chemoprophylaxis in prevention of recurrent urinary infections in women].
    Krcméry S, Hromec J, Gábrisová Z, Tahotný R.
    Vnitr Lek; 2010 Sep 25; 56(9 Suppl):955-60. PubMed ID: 21137167
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Experimental vaccine may curb recurrent urinary tract infections.
    Mayo Clin Womens Healthsource; 2004 Jan 25; 8(1):3. PubMed ID: 14704603
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Prevention of recurrent infection of the upper and lower airways. Multicenter, open study over three months].
    Debelic M, Eckenberger HP.
    Fortschr Med; 1992 Nov 30; 110(30):565-70. PubMed ID: 1468743
    [Abstract] [Full Text] [Related]

  • 11. [Study on clinical effects of tosufloxacin (TFLX) and the long-term low dose therapy for the prophylaxis of recurrent urinary tract infection].
    Sakurai M, Sugimura Y, Arima K, Kawamura J, Saitou K, Tajima K, Nakano S, Satani H, Nagano M, Hoshina A.
    Hinyokika Kiyo; 1994 Mar 30; 40(3):279-84. PubMed ID: 8178752
    [Abstract] [Full Text] [Related]

  • 12. The effects of vaccination with inactivated uropathogenic bacteria in recurrent urinary tract infections of children.
    Nayir A, Emre S, Sirin A, Bulut A, Alpay H, Tanman F.
    Vaccine; 1995 Aug 30; 13(11):987-90. PubMed ID: 8525693
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Changes in pools of autoantibodies and anti-bacterial antibodies in patients suffering from recurrent infections of the urinary tract and undergoing bacterial immunization treatment.
    Stojanović M, Inić-Kanada A, Popović Z, Zivković I, Dimitrijević L.
    Immunol Lett; 2004 Jun 15; 94(1-2):123-33. PubMed ID: 15234544
    [Abstract] [Full Text] [Related]

  • 15. Recurrent urinary tract infection in adult women: diagnosis and treatment.
    Nicolle LE, Ronald AR.
    Infect Dis Clin North Am; 1987 Dec 15; 1(4):793-806. PubMed ID: 3333659
    [Abstract] [Full Text] [Related]

  • 16. Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis.
    Naber KG, Cho YH, Matsumoto T, Schaeffer AJ.
    Int J Antimicrob Agents; 2009 Feb 15; 33(2):111-9. PubMed ID: 18963856
    [Abstract] [Full Text] [Related]

  • 17. [Immunomodulation of recurrent urinary tract infections with Urvakol vaccine].
    Koukalová D, Reif R, Hájek V, Mucha Z, Veselý J, Viktorinová M, Lochman I.
    Bratisl Lek Listy; 1999 May 15; 100(5):246-51. PubMed ID: 10500328
    [Abstract] [Full Text] [Related]

  • 18. Active immunoprophyilaxis with uromune® decreases the recurrence of urinary tract infections at three and six months after treatment without relevant secondary effects.
    Ramírez Sevilla C, Gómez Lanza E, Manzanera JL, Martín JAR, Sanz MÁB.
    BMC Infect Dis; 2019 Oct 28; 19(1):901. PubMed ID: 31660885
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Overview on the clinical studies with Urostim immunostimulator against urogenital infections.
    Nenkov P.
    Adv Exp Med Biol; 2000 Oct 28; 485():325-9. PubMed ID: 11109124
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.